Senior Director, HEOR/RWE GI

1w1 week ago

Revolution Medicines

US · Full-time · $244,000 – $305,000

About this role

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. Its pipeline includes RAS(ON) inhibitors like daraxonrasib (RMC-6236) and elironrasib (RMC-6291) in clinical development. The Senior Director, HEOR/RWE GI leads strategy for assets in pancreatic and colorectal cancer.

This leader develops HEOR/RWE strategy, integrating with development and market access planning. They align with Medical Affairs and Development to design research and deliver evidence for the Integrated Evidence Plan. Responsibilities include executing tactics on time with quality.

The role involves cross-functional matrix teams, providing HEOR/RWE leadership on working groups. They lead partnerships with payers, HTA agencies, and global consortia to shape access strategies and evidence standards. Collaboration occurs with external partners like thought leaders and patient advocates.

Reporting to the Executive Director of HEOR/RWE GI, this position serves as an internal HEOR expert and represents RevMed at conferences. It facilitates communication of value propositions to healthcare professionals. This offers a chance to shape oncology patient care through impactful evidence.

Requirements

Demonstrated success in evidence generation globally
Ability to provide strategic guidance on global product value
Experience as HEOR expert internally and representing externally at industry conferences
Expertise in HEOR/RWE strategies for oncology assets in pancreatic and colorectal cancer
Proficiency in aligning evidence with Integrated Evidence Plans
Strong background in payer and HTA agency partnerships
Skills in real-world evidence generation and partnerships with healthcare organizations
Knowledge of engaging thought leaders, patient advocates, and decision-makers

Responsibilities

Develop and evolve product HEOR/RWE strategy, including integration with development and market access planning
Align with Medical Affairs and Development leadership to design research and deliver evidence consistent with the medical strategy and IEP
Deliver HEOR/RWE tactics with quality and in alignment with agreed upon timing
Provide HEOR/RWE leadership on matrix teams and working groups
Lead enterprise partnerships with payers, HTA agencies, and global consortia to shape access strategy, policies, evidence standards, and evidence generation activities
Work with HEOR/RWE and Medical Affairs leadership to ensure critical value insights are communicated to key internal teams
Provide HEOR evidence addressing needs of patients, healthcare providers, payers, and HTA agencies
Present research findings to internal and external stakeholders and facilitate communication of the value proposition